北京加科思新药研发有限公司

北京加科思新药研发公司成立于2014年，是一家致力于创新药物研发的高新企业，如果要问加科思与其他众多的新药研发公司有什么不同的话，那大的不同就是我们将致力于把加科思打造成一个和科学家共同创业的“梦工场”----我们不是招募全球的人才，我们将携手有志创业的科学家共同创业。这也是公司中文名字的由来，“加”寓意为汇聚、团结一致；科”则意为科学，科研；“思”寓意为思考、专注。 对于一个有创新药研发梦想的科学家和创业者来说，都面临着投资、团队、研发平台等问题，加科思采用“捆绑式创新工场”的模式，致力于解决这些问题。加科思为每一位有发明创造梦想的科学家注册一个公司，为创业的科学家提供新药研发投资、提供涵盖新药研发各个领域和环节的实验室平台、组建好和科学家一起工作的团队----让创业的科学家专心做科研，为创业的科学家提供一个实现梦想的舞台，加科思将“让创业、创新变得更简单”。 加科思是由北京融鑫创业投资中心、北京亦庄国际投资发展有限公司、台湾玉晟投资公司和贝达药业股份有限公司等共同出资成立的新药研发企业。由留美海归博士团队，业内的新药研发及管理团队组成，他们具有数十年的新药创制和研发管理实践经验，在中国有数个有影响力的创新药上市。 公司位于北京市经济技术开发区生物医药园孵化中心，下设合成室、分析室、制剂室、药理部、QA室、注册室、医学部等部门， 公司自成立以来，已启动包含针对恶性肿瘤、败血症两个项目的研发工作，申报发明专利多项，同时公司“捆绑式创新工场”的模式也引起包括北京大学、清华大学等多个科研院所的关注和积极响应，目前已经与北京大学开展合作，共同开发新靶点药物。 “专业、高效、宽厚、优雅“”是加科思的企业文化，我们也同样秉承”Patient、science frist、moneyfollows”的理念，立足世界医药领域的前沿，致力于开发在全球拥有自主知识产权的原研药物，做一个受人尊敬的新药研发企业。 Beijing Jacobio Pharmaceuticals Co. Ltd., a high-tech enterprise founded in 2014, is acompany dedicated to innovative drug discovery and development. We arecommitted to creating a “dream factory” with our scientists, which makesJacobio so unique from other pharmaceutical companies. We will work withaspiring scientists to joint venture together instead of recruiting the world'stop talent, which is exactly the origin of our Chinese company name “Jia SiKe”. “Jia” means gathering together and uniting as one; “Si” means thinking andfocusing; and “Ke” means science and research. For entrepreneurial scientists, there are someissues they would face such as investment, talent team, and R & D platform.Therefore, Jacobio is taking an “Innovation Bundle” model. Jacobio is committedtoaddressing these problems by registering a company forscientists who have a dream of developing innovative drugs. Jacobio providesventure investment for entrepreneurial scientists. Theresearch laboratoryplatformis established to cover almost all fields and aspects of drugdiscovery and development. The team we built with scientists allows them toconcentrate on research, and provides them a stage to realize their dreams. Jacobiowill makeinnovationandentrepreneurshipsimple. JacobioPharmaceuticals Co., Ltd. was founded by Beijing Rongxing venture capitalcenter, Beijing E-TOWN capital, Ltd., Taiwan Yusheng Capital Ltd., and BettaPharmaceutical Co., Ltd. The core R&D team is comprised of PhD returnees, whohave decades of experience in innovative drug development and have brought severalnew drugs to market in China. Thecompany is located in the Beijing Economic and Technological Development ZoneBiomedical Park Incubation Center, composed by synthesis lab, analytical lab,pharmacology lab, formulation lab, QA department, medical department,intellectual property department and so on. Since theestablishment of Jacobio, we have initiated couple of projects with proprietaryintellectual property rights. We will focus on the therapeutic areas which havesignificant impact on human health such as malignant tumors, cardiovascular,septicemia and so forth. Meanwhile,the "Innovation Bundle" model also attracted much attention andpositive response. Lots of famous University and research institutes includingPeking University, Tsinghua University have signed cooperation agreements withus to develop new drugs for innovative targets. “Professional,efficient、generous, elegant” is the corporate culture ofJacobio. Patients and science are at the core of our approach to drugdevelopment. To reach the forefront of the field of medicine, we will createmore and better new drugs to ensure that people have access to innovativetreatments and quality health care.